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Abstract 
Background: We report an unusual case 
involving vaginal perforation associated with 
second trimester dilation and evacuation. 
Review of the literature fails to identify additional 
reports. 
Case: A 22 year G3P1011 female at 16 weeks 
gestation referred for evaluation following 
incomplete dilation and evacuation was found to 
have vaginal perforation, and communication 
with the peritoneal cavity on pelvic examination. 
Examination under anesthesia and laparoscopy 
confirmed multiple vaginal perforations with 
intraperitoneal defects and hematomas but no 
viscus involvement. Cervical dilation was 
accomplished with osmotic dilators placed under 
ultrasound guidance during exam under 
anesthesia, with evacuation completed 
approximately 16 hours later without further 
complication.  
Conclusion: This is the first case of vaginal 
perforation at time of dilation and evacuation 
reported in the literature. Laparoscopy should be 
performed to evaluate for intraabdominal injury 
to bowel, bladder and/or blood vessels. Use of 
osmotic dilators during the second trimester 
could potentially decrease the risk of vaginal 
perforation during the dilation portion of the 
procedure. 
1University of Iowa Carver College of Medicine, 
Iowa City, Iowa 
2University of Iowa Hospitals and Clinics, 
Department of Obstetrics and Gynecology, Iowa 
City, Iowa 
 
  
Introduction 
In the United States, approximately 45% 
of all pregnancies are unintended and 
up to 18% of all pregnancies are 
terminated.1,2 The majority of abortions 
performed in the United States are 
performed prior to 13 weeks (91.6%).3 
Of the remaining abortions performed, 
7.1% were performed between 14 and 
20 weeks’ gestation with only 1.3% 
performed at greater than 21 weeks’ 
gestation.3 Approximately 95% of 
second trimester abortions are 
performed by dilation and evacuation 
(D&E) and their safety is comparable to 
procedures in the first trimester.4 When 
complications arise, they have been 
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reported to be secondary to hemorrhage 
(0.1-0.6%), cervical laceration (up to 
3.3%), retained products of conception 
(<1%), infection (0.1-4%) and uterine 
perforation (0.2-0.5%).5 
A review of the literature did not reveal 
any reports of dilation and evacuation 
complicated by vaginal perforation. The 
purpose of this case report is to alert 
physicians of this complication and its 
management. 
Case Report 
A 22-year-old G3P1011 patient 
presented to a local provider for 
termination of pregnancy at 16 weeks 3 
days gestation by the patients last 
menstrual period (LMP). The patient had 
a history of depression, one previous 
term pregnancy delivered by cesarean 
section, and an uncomplicated first 
trimester medical abortion. The patient 
denied prior abnormal cervical cytology 
or sexually transmitted infection. Her 
body mass index (BMI) was 35.8 with a 
weight of 91.6kg. 
The local provider performed ultrasound 
to confirm gestational age, which was 
consistent with the patient’s LMP.  The 
patient was given 600mcg of buccal 
misoprostol for cervical ripening 
approximately four hours prior to the 
evacuation procedure.  The patient was 
then given 200 mg of oral Doxycycline 
for antibiotic prophylaxis and 800 mg of 
oral Ibuprofen for postoperative pain 
control.  A paracervical block with 10 ml 
of 1% Lidocaine was placed for local 
anesthesia and the patient received 150 
mcg of Fentanyl and 2 mg of Midazolam 
for IV anesthesia. Following betadine 
site preparation and placement of a 
speculum, the cervix was grasped with a 
single tooth tenaculum and was then 
dilated using sequential Pratt dilators to 
49 French.  Amniotomy was performed 
with a 16 mm suction cannula under 
ultrasound guidance with a return of 
clear fluid noted.  The suction cannula 
was then reinserted but no products of 
conception returned.  An attempt was 
made at inserting the Finks forceps 
under ultrasound guidance, but again no 
tissue was returned. The procedure was 
stopped due to concern that cervical 
dilation was not adequate.  The patient 
was given an additional dose of 600 
mcg of buccal misoprostol as well as 10 
units of oxytocin diluted in 500 ml of 
normal saline.  After approximately four 
hours without delivery of products, 
dilation under ultrasound was 
reattempted but there was concern for 
creation of a false passage as well as 
increased patient discomfort.  They 
were unable to determine when or if a 
perforation would have occurred given 
the amniotomy had been successful.  Of 
note, the local provider was an 
experienced family planning physician 
with more than 20 years of experience. 
Upon arrival to our tertiary care facility, 
the patient was noted to be 
hemodynamically stable with normal 
vital signs (pulse 80, blood pressure 
137/69, respiratory rate 17, temperature 
36.8 degrees Celsius).  Laboratory 
testing confirmed the patient was Rh 
positive, with hemoglobin of 10.0 g/dL 
and WBC of 14.9 cells/mm3.  An 
ultrasound performed confirmed a 16 to 
18 week sized intrauterine gestation 
with no fetal cardiac activity and minimal 
fluid around the fetus.  Upon palpation 
of the vagina, a 1 to 2 cm defect that 
tracked cephalad was noted in the 
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posterior vaginal wall inferior to the 
cervix.  The cervix was abraded and the 
anterior lip was avulsed from the 
cervical stromal tissue.  In addition, 
there was a defect in the vaginal wall 
anterior to the cervix.  The uterus 
palpated 16 to 18 week size.  
Rectovaginal examination was not 
performed secondary to patient 
discomfort with the examination.   
The patient was taken to the operating 
room for an exam under anesthesia, 
diagnostic laparoscopy, and possible 
dilation and evacuation versus osmotic 
dilator placement with interval uterine 
evacuation.  In the operating room a 2 
cm defect in the posterior vaginal wall 
that tracked cephalic and entered the 
posterior cul de sac was confirmed 
(Image 1) as well as a 1 to 2 cm anterior 
vaginal wall defect that tracked laterally 
to the right with intraperitoneal 
communication at the right broad 
ligament (Image 2).  The cervix was 
long (approximately 4 cm), 1 cm dilated 
and firm.  General surgery was 
consulted to evaluate potential bowel 
injury.  A rigid flexible sigmoid 
proctoscopy and a thorough 
examination of the bowel revealed no 
injury or rectal perforation.   
 
 
Image 1: Laparoscopic photograph with arrow depicting posterior vaginal wall 
perforation exit into the posterior cul de sac. 
A 4 cm hematoma was noted in the right 
pelvic side wall that was stable 
throughout the laparoscopic portion of 
the case.  No attempt to repair the 
vaginal defects was made.  Given the 
presence of significant cervical length 
with poor cervical dilation, the decision 
was made to place osmotic dilators 
under ultrasound guidance and 
complete the uterine evacuation the 
following day.  A total of five #4 Dilapan 
and one #3 Laminaria were inserted.  
Sixteen hours after osmotic dilator 
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placement, an uncomplicated ultrasound 
guided uterine evacuation and 
placement of an etonogestrel implant 
was completed.  Vaginal defects 
appeared stable and did not require 
repair.  The patient remained 
hospitalized and received antibiotics for 
24 hours before being discharged home 
with a seven day course of doxycycline 
100 mg twice daily and metronidazole 
500 mg twice daily.  The patient 
returned to the clinic three weeks later 
and the vaginal wall was noted to be 
intact upon pelvic exam and healing 
well.  Pelvic rest for a total of six weeks 
was recommended.  
 
 
Image 2: Laparoscopic photograph with arrow depicting anterior vaginal wall 
perforation exit through the posterior leaf of the right broad ligament and 
resulting pelvic sidewall hematoma. 
Discussion 
Vaginal wall perforation during dilation 
and evacuation has not been previously 
reported in the literature.  In this case, 
the cervical length, firm consistency and 
lack of dilation with osmotic dilators may 
have contributed to the complication.  
While the referring provider was unsure 
of when or how the perforation occurred, 
a review of the literature recommends 
against use of rigid dilators alone in the 
second trimester and thus pre-
procedure preparation is essential.6  
Cervical preparation prior to dilation and 
evacuation can be done 
pharmacologically, namely with 
mifepristone and/or misoprostol, or 
mechanically with osmotic dilators.  
Insufficient cervical dilation is an 
independent risk factor for 
complications.7 A prospective cohort of 
more than 11,000 second trimester D&E 
procedures showed a protective effect 
with pre-procedure osmotic dilators with 
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a decreased cervical laceration rate.8 
Misoprostol alone, as used in this case, 
achieves less cervical dilation than 
osmotic dilators and may increase the 
likelihood of inadequate cervical 
preparation causing a challenging or 
failed procedure.  In one study of over 
2200 second trimester D&E’s between 
12-18 weeks, 18% of subjects had 
inadequate dilation with misoprostol 
alone as compared to 2% with osmotic 
dilators (p<0.004).9  
Given the infrequency of complications 
with D&E, existing studies have been 
underpowered to detect differences in 
complication rates between misoprostol 
alone versus osmotic dilators.  However, 
Nucatola et al., showed a uterine 
perforation rate of 0.45% with 400 mcg 
of misoprostol alone given 90 minutes 
prior to D&E procedures between 12-16 
weeks gestation and no cervical 
lacerations occurred.10 This rate is 
similar to those suggested in other 
studies of D&E procedures. Shortening 
the pre-procedure preparation to allow 
women same day procedures with 
misoprostol alone versus overnight 
dilators has shown improved patient 
satisfaction, but providers note less 
satisfaction with cervical preparation 
and more women required mechanical 
dilation.11 A randomized control trial 
comparing overnight osmotic dilators 
and dilators plus 400 mcg buccal 
misoprostol 3 hours prior to procedure 
found no difference in operative time 
between cohorts and a trend suggestive 
of no increase in complication rates.8 
While the study was underpowered, it 
did demonstrate initial dilation was 
greater with dilators plus misoprostol 
compared to dilators alone (2.4 cm 
compared with 2.0 cm, p=0.007) in the 
16-18 week gestation group.8 Same day 
procedures are possible with the use of 
osmotic dilators, especially with the use 
of Dilapan-S, which dilate quicker (4-6 
hours versus 12-24 hour with laminaria) 
and increase more per volume (4 versus 
3 times dehydrated dilator).12,13 Thus, it 
is unclear if the use of osmotic dilators 
decreases the risk of major 
complications, but several studies have 
shown improved cervical dilation and 
provider satisfaction as compared to 
misoprostol alone. 
Maternal obesity has been suggested as 
a risk factor for complications with 
abortion and this patient’s BMI was 
notable at 35.8. Dark et al. reported a 
trend for increased procedure difficulty, 
procedure time and blood loss with 
increasing body mass index but their 
study was underpowered.14 In contrast, 
Lederle et al. found no increase in the 
rate of complications associated with 
increased BMI.15 Although maternal 
obesity can make abortion procedures 
more technically difficult, an association 
with increased complications has not 
been definitively shown. 
Regarding management of vaginal 
perforation, we utilized diagnostic 
laparoscopy to evaluate for 
intraabdominal injury which is the same 
management recommended following 
uterine perforation.9 Given the potential 
for injury to the rectum, sigmoid colon or 
small bowel, intraoperative evaluation 
by general surgery or another surgical 
sub-specialist trained to perform bowel 
resections should be considered.16  
Although previous literature concluded 
laparoscopy to be inadequate for bowel 
evaluation after uterine perforation, 
improved technology and gynecologist 
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training has allowed the use of this 
minimally invasive approach rather than 
laparotomy.17 Laparoscopy also allows 
for evaluation and control of bleeding if 
injury is sustained to the pelvic 
vasculature.  While laparoscopic guided 
uterine evacuation has been described, 
we chose to optimize cervical dilation by 
placing osmotic dilators with ultrasound 
guidance prior to completion of uterine 
evacuation given the presence of a firm 
and long cervix.9,18 Finally, we opted to 
forgo repair of the vaginal perforations 
thus allowing healing by secondary 
intention, as well as prophylactic 
antibiotics given the risk for subsequent 
abscess formation.   
Conclusions 
In conclusion, abortion related morbidity 
and mortality events remain clinically 
and statistically rare.19 Abortion is a 
much safer procedure than delivery in 
the US.20 Prompt recognition and 
appropriate intervention are essential to 
ensure optimal outcomes. The use of 
osmotic dilators during the second 
trimester could potentially decrease the 
risk of vaginal perforation during the 
dilation portion of the procedure by 
increasing pre-procedure cervical 
ripening.  
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